BioSpot 2018 Conference in Prague attracted global investors

Ambitious Czech biotechnology inventions were presented to major domestic and foreign investors at the international BioSpot 2018 conference held on March 1, 2018, in Prague, Czech Republic.

The annual BioSpot Conference aims to present the most outstanding projects not only from Czech Republic but also from other countries from Central Europe. And it is on the rise. BioSpot 2018 saw as many as 19 ambitious inventions and technologies presented in oral and poster sessions. Among them were e.g. use of nanoparticles for cancer treatment, use of neurosteroids for treatment of neuropathic pain, and analysis of exhaled breath for diagnosis of lung cancer, a rapid detection of antibiotic resistance. Growing attendance and positive response to the conference from representatives of major global investors points to the fact that Central European science has much to offer.

i&i Prague was one of the main partners of the Conference. “i&i Prague is a business incubator formed not long ago where we want to gather interesting research projects, develop them, and aid at putting them on the market, ideally also locate a suitable investor. It’s one of the reasons a conference such as BioSpot is important for us,” explains i&i Prague’s CEO Jaromír Zahrádka.

The fourth annual BioSpot Conference will be held on March 6, 2019 at the Center for Contemporary Art DOX in Prague.

The full press release is available here.

Theme picture of BioSpot 2018